On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

Goulis Ioannis; Karatapanis Stylianos; Akriviadis Evangelos; Deutsch Melanie; Dalekos George N.; Raptopoulou-Gigi Maria; Mimidis Konstantinos; Germanidis George; Drakoulis Christos; Triantos Christos; Zintzaras Elias; Bakalos Georgios; Papatheodoridis George

首页> 外文期刊>Liver international : >On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

【24h】

On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

机译：HbeAg阴性慢性乙型肝炎患者对聚乙二醇干扰素α-2a持续应答的治疗上预测

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background & AimsWe assessed predictors of response in HBeAg-negative chronic hepatitis B patients treated with peginterferon alfa-2a in routine clinical practice.

机译：背景与目的我们在常规临床实践中评估了接受聚乙二醇干扰素α-2a治疗的HBeAg阴性慢性乙型肝炎患者反应的预测因子。

著录项

来源
《Liver international :》 |2015年第5期|共9页
作者
Goulis Ioannis; Karatapanis Stylianos; Akriviadis Evangelos; Deutsch Melanie; Dalekos George N.; Raptopoulou-Gigi Maria; Mimidis Konstantinos; Germanidis George; Drakoulis Christos; Triantos Christos; Zintzaras Elias; Bakalos Georgios; Papatheodoridis George;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
chronic hepatitis B; HBeAg-negative; HBsAg quantification; peginterferon; prediction; sustained response; treatment;

机译：慢性乙型肝炎;HBeAg阴性;HBsAg定量;聚乙二醇干扰素;预测;持续缓解;治疗;

相似文献

外文文献
中文文献
专利

1. On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients [J] . Goulis Ioannis, Karatapanis Stylianos, Akriviadis Evangelos, Liver international : . 2015,第5期

机译：HbeAg阴性慢性乙型肝炎患者对聚乙二醇干扰素α-2a持续应答的治疗上预测
2. Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B [J] . Teerha Piratvisuth, George Lau, You-Chen Chao, Hepatology International . 2008,第1期

机译：亚洲人HBeAg阳性和HBeAg阴性的慢性乙型肝炎患者接受或不接受拉米夫定对peginterferon alfa-2a（40 kD）的持续应答
3. Sustained response to peginterferon alfa-2a (40?kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B [J] . Teerha Piratvisuth, George Lau, You-Chen Chao, Hepatology international . 2008,第1期

机译：亚洲人HBeAg阳性和HBeAg阴性的慢性乙型肝炎患者对有或无拉米夫定的peginterferon alfa-2a（40？kD）的持续应答
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. Assessment of health-related quality of life in adult chronic hepatitis C patients with different categories of disease and sustained response to Intron(rtm) A. [D] . Martino, Frances P. 1997

机译：评估患有不同疾病类别并持续对Intron（rtm）A做出反应的成人慢性丙型肝炎患者的健康相关生活质量。
6. Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B [O] . Teerha Piratvisuth, George Lau, You-Chen Chao, 2008

机译：有HBeAg阳性和HBeAg阴性的慢性乙型肝炎患者对有或无拉米夫定的聚乙二醇干扰素alfa-2a（40kD）的持续反应
7. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels [O] . Vincent Rijckborst, Bettina E. Hansen, Yilmaz Cakaloglu, 2010

机译：利用HBsAg和HBV DNA水平，对HBeAg阴性慢性乙型肝炎的Peginterferon Alfa-2a的早期治疗预测

On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅